CERNITIN
Live / Applied — Fifth extension granted (statement of use) (as of 01 Dec 2025)
What this means for you
Not registered yet, but its 14 Jan 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97219331
- Mark type
- Stylized text
- Filed
- 14 Jan 2022
- Published for opposition
- 06 Dec 2022
- Attorney of record
- Camille M. Miller
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for treatment of BPH and prostatitis; Pollen dietary supplements; Natural remedy preparations containing pollen extract for the treatment of BPH and prostatitis; Dietetic preparations adapted for medical purposes; food supplements for treating BPH and prostatitis; Nutraceuticals for the treatment of BPH and prostatitis; Nutraceuticals for use as a dietary supplement for treatment of BPH and prostatitis
Owner
- Aktiebolaget Cernelle, Ängelholm, SE
- Aktiebolaget Cernelle, Ängelholm, SE
Prosecution history
- 02 Dec 2025 — TEAS STATEMENT OF USE RECEIVED
- 01 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Dec 2025 — SOU EXTENSION 5 GRANTED
- 16 Jun 2025 — SOU EXTENSION 5 FILED
- 16 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Jan 2025 — SOU EXTENSION 4 GRANTED
- 15 Jan 2025 — SOU EXTENSION 4 FILED
- 15 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 13 Jun 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Jun 2024 — SOU EXTENSION 3 GRANTED
- 03 Jun 2024 — SOU EXTENSION 3 FILED
- 03 Jun 2024 — SOU TEAS EXTENSION RECEIVED
- 16 Dec 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Dec 2023 — SOU EXTENSION 2 GRANTED